Skip to main content
Kasia Lipska, MD, Endocrinology, New Haven, CT, Yale-New Haven Hospital

KasiaJLipskaMD

Endocrinology • New Haven, CT

Diabetes, Lipid Metabolism

Assistant Professor of Medicine (Endocrinology), Yale School of Medicine

Join to view full profile

Dr. Lipska is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Lipska's full profile

Already have an account?

  • Office

    333 Cedar St
    Yale University Med School/Int Medicine (Endocrine)
    New Haven, CT 06510
    Phone+1 203-737-4853
  • Is this information wrong?

Summary

  • I am an endocrinologist at the Yale School of Medicine and a Clinical Investigator at the Yale-New Haven Hospital Center for Outcomes Research and Evaluation (CORE). My research program seeks to better understand the balance of benefits and harms of glucose-lowering therapy in older adults with type 2 diabetes. My current research projects are primarily focused on severe hypoglycemia. I am investigating trends in admissions for hypoglycemia among the elderly Medicare population; race, sex, and age disparities in these admissions; using qualitative research methods to explore reasons for hypoglycemia admissions; examining key risk factors for hypoglycemia; and developing prediction models for hypoglycemia. Based on these data, I seek to develop and implement decision support tools to help clinicians and patients make better decisions about their care. My overall goals are to generate data that patients and clinicians need—data which currently do not exist—so that they can make better, smarter treatment decisions.

    In addition, Dr. Lipska works at CORE on the development of ambulatory care quality measures for the Centers for Medicare & Medicaid Services (CMS). She is currently leading the development of an outcome measure of care quality among people with diabetes mellitus.

    • The Global Diabetes Epidemic

    Within the last few decades, South Asia has experienced a rapid economic transition paralleled by an epidemiological shift in disease patterns. Recently, when I

    When Diabetes Treatment Goes Too Far

    NEW HAVEN - ONE of my elderly patients has Type 2 diabetes and heart disease. He takes a number of medications, including insulin to control his blood sugar lev

    Break Up the Insulin Racket

    ONE of my patients - whom I will call Mrs. B - is a 78-year-old who has had Type 2 diabetes for over 30 years. She takes several injections of insulin each day.

Education & Training

  • Yale-New Haven Hospital
    Yale-New Haven HospitalPost-Doctoral Fellowship, Robert Wood Johnson Clinical Scholars Program, 2009 - 2011
  • Yale University
    Yale UniversityM.H.Sc., 2011
  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 2007 - 2009
  • Brigham and Women's Hospital
    Brigham and Women's HospitalResidency, Internal Medicine, 2003 - 2006
  • Harvard Medical School
    Harvard Medical SchoolClass of 2003
  • Yale University
    Yale UniversityB.S., Molecular Biochemistry and Biophysics, Cum Laude, 1997

Certifications & Licensure

  • CT State Medical License
    CT State Medical License 2012 - 2024
  • MA State Medical License
    MA State Medical License 2006 - 2007
  • American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

  • Young Investigator Career Development Award in Geriatric Endocrinology ADA-ASP, 2013
  • Grants for Early Medical/Surgical Specialists’ Transition to Aging (GEMSSTAR) Award 2013
  • Pepper Research Career Development Core Scholar Award 2013
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Comparative Effectiveness of Generic vs Brand-Name Levothyroxine in Achieving Normal Thyrotropin Levels  
    Juan P Brito, Robert C Smallridge, Victor Bernet, Kasia J Lipska, JAMA Network Open
  • Is the Over-the-Counter Availability of Human Insulin in the United States Good or Bad?  
    Kasia J. Lipska, Madeline McCrary, JAMA
  • Availability and Affordability of Essential Medicines: Implications for Global Diabetes Treatment  
    Kasia Lipska, Irl B. Hirsch, Current Diabetes Reports
  • Join now to see all

Lectures

  • Lilacs, Lactate, Lies, and Labels 
    1/1/2016
  • Type 2 Diabetes in Older Patients 
    1/1/2016
  •  
    New Orleans, LA - 1/1/2016
  • Join now to see all

Other

  • Break up the insulin racket 
    Lipska K, The New York Times
    1/20/2016
  • When diabetes treatment goes too far 
    Lipska K, The New York Times
    1/12/2015
  • The global diabetes epidemic 
    Lipska K, The New York Times
    1/25/2014
  • Join now to see all

Press Mentions

  • The Price of Insulin: A Q&A with Kasia Lipska
    The Price of Insulin: A Q&A with Kasia LipskaApril 27th, 2023
  • A Verywell Report: Insulin Price Cuts Barely Move the Needle for Americans
    A Verywell Report: Insulin Price Cuts Barely Move the Needle for AmericansApril 27th, 2023
  • Insulin: 1.3 Million Americans with Diabetes Rationed Their Supply in the Past Year, Study Finds
    Insulin: 1.3 Million Americans with Diabetes Rationed Their Supply in the Past Year, Study FindsOctober 18th, 2022
  • Join now to see all

Hospital Affiliations

Dr. Kasia Lipska, Dr. Kasia Lipska, MD, Dr. K Lipska, Dr. Kasia J Lipska